Why markets already priced in a vaccine approval, stellar gains from AIM stocks in 2020, retail’s latest challenge and dealing with NS&I’s punishing rate cuts
The UK’s status as the first country in the world to approve Pfizer’s Covid vaccine failed to move stock markets on the day of the news. Listen to the podcast to find out why markets reacted in this way.
Tom Sieber from Shares magazine joins the show to discuss the reasons why the AIM market has done nearly as well as the US S&P 500 in 2020 and significantly outperformed large cap UK stocks in the FTSE 100.
The podcast looks at the large rate cuts on NS&I accounts and what savers can do to improve their situation. And the team also debate the latest in the retail sector after Debenham’s struggles and Arcadia going into administration.
Presented by AJ Bell’s Dan Coatsworth and Laith Khalaf
Latest podcasts:
In this week’s episode, Tom Sieber and Danni Hewson digest the latest market developments from both sides of the Atlantic, with AJ Bell shares and markets... Read more
Money & Markets Podcast | Fri, 31/10/2025 - 09:17
Inflation joy: good news for pensioners and borrowers
The AJ Bell Money & Markets podcast team give you the latest insights on issues affecting your personal finances, investments and pensions.
Dan... Read more
Money & Markets Podcast | Fri, 24/10/2025 - 09:33
What is active and passive investing?
This week on the AJ Bell Money Matters podcast, Danni and Charlene discuss rumours about the upcoming budget and how they could affect your finances.
... Read moreMoney Matters Podcast | Wed, 22/10/2025 - 09:01